Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment

Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment

Abstract Longitudinal serological proteomic dynamics during antiviral therapy (AVT) in chronic hepatitis B (CHB) patients with liver fibrosis remain poorly characterized. Here, using four-dimensional data-independent acquisition mass spectrometry (4D-DIA-MS), paired liver biopsy (LBx)-proven serum s...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mengyang Zhang, Shuyan Chen, Xiaoning Wu, Jialing Zhou, Bingqiong Wang, Tongtong Meng, Rongxuan Hua, Yameng Sun, Hong You, Wei Chen
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-08-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-025-63006-z
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Diagnostic value of serologic biomarkers for the detection of liver fibrosis in non-alcoholic fatty liver disease
by: Mahsa Mohammadi, et al.
Published: (2025-03-01)

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
by: Hai Li, et al.
Published: (2016-05-01)

Effect of Allostatic Load on hepatic steatosis and fatty liver-associated liver fibrosis
by: Lei Zhang, et al.
Published: (2025-07-01)

Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests
by: Huiyul Park, et al.
Published: (2025-07-01)

Predictive Value of a Noninvasive Serological Hepatic Fibrosis Scoring System in Cirrhosis Combined with Oesophageal Varices
by: Feiyue Zhang, et al.
Published: (2018-01-01)

The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
by: Qian Ding, et al.
Published: (2019-01-01)

Quantitative Proteomic Study Reveals Amygdalin Alleviates Liver Fibrosis Through Inhibiting mTOR/PDCD4/JNK Pathway in Hepatic Stellate Cells
by: Huang H, et al.
Published: (2025-05-01)

Serological Monitoring as an Indicator of Population Immunity against Hepatitis B in the Population of the Russian Federation
by: D. V. Solov’yov, et al.
Published: (2024-11-01)

Dynamics of compartment-specific proteomic landscapes of hepatotoxic and cholestatic models of liver fibrosis
by: Marketa Jirouskova, et al.
Published: (2025-04-01)

Integrative metabolomics and proteomics reveal the effect and mechanism of Zi Qi decoction on alleviating liver fibrosis
by: Xiaoying Chen, et al.
Published: (2024-11-01)

Author Correction: The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
by: Qian Ding, et al.
Published: (2025-07-01)

The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature
by: Olga H. Orasan, et al.
Published: (2019-10-01)

SEROLOGY FOR HEPATITIS B AMONG HEALTH PROFESSIONALS
by: Suzana de Almeida Fraguas, et al.
Published: (2012-11-01)

SEROLOGY FOR HEPATITIS B AMONG HEALTH PROFESSIONALS
by: Suzana de Almeida Fraguas, et al.
Published: (2012-11-01)

SEROLOGY FOR HEPATITIS B AMONG HEALTH PROFESSIONALS
by: Suzana de Almeida Fraguas, et al.
Published: (2012-11-01)

SEROLOGY FOR HEPATITIS B AMONG HEALTH PROFESSIONALS
by: Suzana de Almeida Fraguas, et al.
Published: (2012-11-01)

Advancing Chronic Liver Disease Diagnoses: Targeted Proteomics for the Non-Invasive Detection of Fibrosis
by: Andrea Villanueva Raisman, et al.
Published: (2025-01-01)

Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”
by: Chen-Hua Liu, et al.
Published: (2025-04-01)

Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
by: GONG Xiaoqian, et al.
Published: (2025-04-01)

Morphological and ultrasound features of liver fibrosis in children with autoimmune hepatitis
by: V. S. Berezenko, et al.
Published: (2018-12-01)

Alterations in the “Gut–Liver Axis” on Rats with Immunological Hepatic Fibrosis
by: Zhaoyao Qi, et al.
Published: (2023-01-01)

Hepatic ferroptosis induced by Clonorchis sinensis exacerbates liver fibrosis.
by: Haoyang Zhang, et al.
Published: (2025-06-01)

Morphogenesis of the liver fibrosis development and progression in chronic hepatitis C
by: M. A. Shishkin
Published: (2015-04-01)

Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study
by: Xiaoxian Yang, et al.
Published: (2025-03-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markers
by: A. F. Sheptulina, et al.
Published: (2016-08-01)

Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)

Serological and molecular survey of hepatitis E virus in pets in shaanxi, China
by: Yiyang Chen, et al.
Published: (2025-07-01)

Heparan sulfate proteoglycan-mediated internalization of extracellular vesicles ameliorates liver fibrosis by targeting hepatic stellate cells
by: Rongrong Li, et al.
Published: (2022-12-01)

Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B
by: Zhiyuan Chen, et al.
Published: (2024-11-01)

Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp
by: Mahmud Mahamid, et al.
Published: (2017-01-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis
by: Ying Wang, et al.
Published: (2024-03-01)

Liver fibrosis assessment by transient elastography in patients with liver cirrhosis after hepatitis C virus eradication
by: E. A. Nabatchikova, et al.
Published: (2020-03-01)

Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.
by: Emilie Fugier, et al.
Published: (2014-01-01)

Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models
by: Thomas Sorz-Nechay, et al.
Published: (2025-07-01)

High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis
by: Bianqiao Cheng, et al.
Published: (2024-01-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)